0.5mg retatrutide Injection: Package Insert / Prescribing Info Retatrutide 5mg - Pro Peptide

The Croaie GLP-1 + GIP packaging displays fake pharmaceutical seals (ISO, GMP, USP, FCC) and Made in France badges to appear clinically validated

An oral Mazdutide or Retatrutide formulation would dramatically expand potential market reach

In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide

A study that investigated the impact of GLP-1 receptor agonists on infectious (influenza) and non-infectious (bleomycin-induced) lung inflammation in wild-type and GLP-1 receptor knockout mice revealed that in the absence of the GLP-1 receptor, bleomycin-induced lung injury was less severe, while activation of the GLP-1 receptor was correlated with increased pulmonary inflammation mediated through the sympathetic nervous system

Furthermore, Covid-19 may induce substantial alterations of gut microbiota due to the direct invasion of enterocytes with the progression of intestinal inflammation

It is also a great option for patients who want to maintain their weight loss, but do not want to continue full-dose injections